Laser Destroys Atherosclerosis PlaquesMay 07, 2004Russian medical professionals are trying to fight atherosclerosis by means of low-intensity infrared laser therapy. The relevant clinical tests are demonstrating successful results. Atherosclerosis vascular diseases have become the principal cause of disability or death for the population of industrially developed countries. Atherosclerosis plaques cause stenosis of the vessel lumen and restrict normal blood circulation which leads to the development of ischemia, brain strokes, encephalopathy, clogged leg vessels and many other diseases. Though there are considerable achievements in fighting atherosclerosis, medicine has not yet succeeded in conquering it. The main problem is created by atherosclerosis plaques which are hard to get rid of (operations entail various complications). Experts from the Medical Radiological Scientific Center, Russian Academy of Medical Sciences, headed by Academician A.F. Tsyba propose using low-intensity infrared laser radiation (LILR) for this purpose. The scientists have conducted laboratory and clinical tests for several years and have made certain of the effectiveness of applying LILR for atherosclerosis treatment. Low-intensity infrared laser radiation does not damage tissues and does not cause mutations, so it can be used for therapy purposes. Medical scientists from Obninsk applied the Gallium-Arsenide laser with 890 nm wavelength, its radiation penetrating into the skin and most tissues 6-8 cm deeper than that of other LILR types does. The researchers used the pulse radiation method (pulse length at least 50 ns, maximum capacity at least 5W) so that the tissues located at maximal depth could receive as much energy as possible and could not "get used" to the laser exposure. As is customary, the tests were started on rats and then, having selected the optimal radiation modes for specific cases, the researchers got down to the clinical testing. Applying LILR, the researchers examined and cured 196 patients suffering from leg vascular diseases; 98 males suffering from encephalopathy caused by atherosclerosis of aorta, lung artery and brain vessels; 133 patients with heart diseases. The patients underwent 10-30 LILR treatment séances 10 minutes each: the areas of tissue with diseased vessels underneath were exposed to radiation. The physicians monitored the treatment results with the help of the most advanced diagnostic equipment. In all cases the patients who had undergone the LILR treatment felt much better. The monitoring showed that the vessels having been exposed to radiation grew wider and were filled with blood while atherosclerosis plaques grew smaller. Better still, if the patients are treated by radiation along with the conventional medicine. In such cases the clinical effect of a single séance lasts 24 hours and that of a course of treatment - for about a year. The patients with heart diseases took the most of the clinical tests. A pseudotherapy background group was formed of them (they were treated with the radiator switched off). They did not feel better but the physicians ascertained that the patients were cured with the help of laser and not by autohypnosis. The results of laboratory experiments and clinical research have led the scientists to the conclusion that LILR can be effectively applied in complex treatment of atherosclerosis damages of brain vessels, myocardium and peripheral arteries. Informnauka (Informscience) Agency |
|||||||||||||||||||||
| Related Atherosclerosis Current Events and Atherosclerosis News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Vitamin B niacin offers no extra benefit to statin therapy in seniors already diagnosed with CAD The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows. Early end to key study on benefits of niacin, a B vitamin, in keeping arteries open was premature Heart experts at Johns Hopkins are calling premature the early halt of a study by researchers at Walter Reed Army Medical Center and Washington Hospital Center on the benefits of combining extended-release niacin, a B vitamin, with cholesterol-lowering statin medications to prevent blood vessel narrowing. Can charcoal fight heart disease in kidney patients? Charcoal may provide a new approach to managing the high rate of heart disease in patients with advanced kidney disease, according to preliminary research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. Experts unveil new CVD guidelines and position papers Several new guidelines and position papers offering the most up to date information to ensure that clinicians practice evidence-based medicine were released at the Canadian Cardiovascular Congress 2009 this week. Canadian scientists link fat hormone to death from potentially deadly blood infection A new Canadian study has found that lower-than-normal levels of a naturally-occurring fat hormone may increase the risk of death from sepsis-an overwhelming infection of the blood which claims thousands of lives each year. Healthy neighborhoods may be associated with lower diabetes risk Individuals living in neighborhoods conducive to physical activity and providing access to healthy foods may have a lower risk of developing type 2 diabetes in a five-year period, according to a report in the October 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Liver cells grown from patients' skin cells Scientists at The Medical College of Wisconsin in Milwaukee have successfully produced liver cells from patients' skin cells opening the possibility of treating a wide range of diseases that affect liver function. National report shines light on lupus 50-year treatment drought Today, The Lewin Group, a national health care consulting firm, issued recommendations on ways to overcome the barriers that have obstructed lupus drug development resulting in no new drug approval for this disease in more than 50 years - since the Eisenhower Administration. Calcium scans may be effective screening tool for heart disease A simple, non-invasive test appears to be an effective screening tool for identifying patients with silent heart disease who are at risk for a heart attack or sudden death. More Atherosclerosis Current Events and Atherosclerosis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||